12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights 1 hour ago
Movers
Gainers Edesa Biotech (NASDAQ:EDSA) stock moved upwards by 39.0% to $2.98 during Monday's regular session. The market value of their outstanding shares is at $20.6 million. Heron Therapeutics (NASDAQ:HRTX) stock
Gainers
- Edesa Biotech (NASDAQ:EDSA) stock moved upwards by 39.0% to $2.98 during Monday's regular session. The market value of their outstanding shares is at $20.6 million.
- Heron Therapeutics (NASDAQ:HRTX) stock rose 31.94% to $0.39. The market value of their outstanding shares is at $55.6 million. As per the news, the Q3 earnings report came out today.
- Modular Medical (NASDAQ:MODD) shares moved upwards by 28.19% to $1.71. The market value of their outstanding shares is at $10.8 million.
- Delcath Systems (NASDAQ:DCTH) stock moved upwards by 28.18% to $19.14. The market value of their outstanding shares is at $518.0 million. The company's, Q3 earnings came out today.
- Iambic Therapeutics (NASDAQ:IAM) stock rose 26.83% to $12.9. The company's market cap stands at $482.0 million.
- Akebia Therapeutics (NASDAQ:AKBA) stock moved upwards by 25.59% to $0.5. The market value of their outstanding shares is at $111.4 million. The company's, Q3 earnings came out 2 days ago.
Losers
- Zura Bio (NASDAQ:ZURA) shares declined by 73.0% to $1.1 during Monday's regular session. The company's market cap stands at $393.9 million.
- Faeth Therapeutics (NASDAQ:FTH) stock fell 51.05% to $10.79. The company's market cap stands at $568.4 million. The company's, Q3 earnings came out 4 days ago.
- Abeona Therapeutics (NASDAQ:ABEO) stock fell 37.53% to $2.6. The company's market cap stands at $238.4 million. As per the news, the Q3 earnings report came out today.
- Karyopharm Therapeutics (NASDAQ:KPTI) stock fell 31.88% to $0.04. The company's market cap stands at $1.2 million.
- Ionis Pharmaceuticals (NASDAQ:IONS) stock declined by 27.38% to $28.63. The market value of their outstanding shares is at $6.5 billion. As per the news, the Q3 earnings report came out today.
- Janux Therapeutics (NASDAQ:JANX) shares decreased by 23.77% to $13.44. The company's market cap stands at $1.0 billion. As per the press release, Q3 earnings came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.